Vikram Purohit

Stock Analyst at Morgan Stanley

(0.63)
# 3,933
Out of 4,911 analysts
162
Total ratings
23.21%
Success rate
-16.42%
Average return

Stocks Rated by Vikram Purohit

Recursion Pharmaceuticals
Jul 3, 2025
Assumes: Equal-Weight
Price Target: $5
Current: $6.49
Upside: -22.96%
Halozyme Therapeutics
May 14, 2025
Downgrades: Equal-Weight
Price Target: $73$62
Current: $58.24
Upside: +6.46%
Ascendis Pharma
May 5, 2025
Upgrades: Overweight
Price Target: $180$250
Current: $167.47
Upside: +49.28%
Incyte
Mar 24, 2025
Maintains: Equal-Weight
Price Target: $69$65
Current: $70.20
Upside: -7.41%
Axsome Therapeutics
Feb 27, 2025
Maintains: Overweight
Price Target: $125$190
Current: $100.83
Upside: +88.44%
Zenas BioPharma
Dec 11, 2024
Maintains: Overweight
Price Target: $40$35
Current: $15.78
Upside: +121.80%
Foghorn Therapeutics
Sep 24, 2024
Maintains: Equal-Weight
Price Target: $6$9
Current: $6.19
Upside: +45.40%
Genmab
Sep 11, 2024
Maintains: Equal-Weight
Price Target: $31
Current: $23.40
Upside: +32.48%
Absci
Jul 3, 2024
Initiates: Overweight
Price Target: $7
Current: $2.89
Upside: +142.21%
ABIVAX Société Anonyme
Apr 11, 2024
Maintains: Equal-Weight
Price Target: $15$16
Current: $66.49
Upside: -75.94%
Initiates: Overweight
Price Target: $30
Current: $4.33
Upside: +592.84%
Maintains: Equal-Weight
Price Target: $20$22
Current: $8.80
Upside: +150.00%
Maintains: Overweight
Price Target: $45$10
Current: $14.86
Upside: -32.71%
Downgrades: Equal-Weight
Price Target: $46$6
Current: $3.18
Upside: +88.68%
Maintains: Overweight
Price Target: $43$42
Current: $8.96
Upside: +368.75%
Maintains: Equal-Weight
Price Target: $20$23
Current: $0.92
Upside: +2,345.65%
Maintains: Equal-Weight
Price Target: $38$41
Current: $45.79
Upside: -10.46%
Maintains: Equal-Weight
Price Target: $120$40
Current: $31.69
Upside: +26.22%
Initiates: Equal-Weight
Price Target: $13
Current: $3.29
Upside: +295.14%
Maintains: Equal-Weight
Price Target: $39$38
Current: $22.23
Upside: +70.94%
Maintains: Equal-Weight
Price Target: $24$20
Current: $11.09
Upside: +80.34%
Maintains: Underweight
Price Target: $11$10
Current: $11.03
Upside: -9.34%
Initiates: Overweight
Price Target: $22
Current: $1.93
Upside: +1,039.90%
Maintains: Equal-Weight
Price Target: $40$20
Current: $9.46
Upside: +111.53%